Advice

following an abbreviated submission:

dorzolomide / timolol preservative-free unit-dose eye drops (COSOPTĀ®) are accepted for restricted use in NHS Scotland for the treatment of elevated intra-ocular pressure in patients with open-angle glaucoma and pseudo-exfoliative glaucoma when topical beta-blocker monotherapy is not sufficient.

This preparation is substantially more expensive than the equivalent multi-dose eye drop preparation and should be restricted to use in patients for whom a combination of these two agents is appropriate and who have proven sensitivity to the preservative benzalkonium chloride.

Download detailed advice29KB (PDF)

Download

Medicine details

Medicine name:
dorzolamide + timolol (Cosopt)
SMC ID:
293/06
Indication:
Elevated intra-ocular pressure in patients with open-angle glaucoma and pseudo-exfoliative glaucoma
Pharmaceutical company
MSD
BNF chapter
Eye
Submission type
Abbreviated
Status
Restricted
Date advice published:
11 December 2006